These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19452649)

  • 1. Study of anti-HIV gel shows promise--what's the next step? Look to upcoming results from Phase III trial.
    AIDS Alert; 2009 May; 24(5):55-7. PubMed ID: 19452649
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug firms donate compounds for anti-HIV gel.
    Towie N
    Nature; 2005 Nov; 438(7064):6-7. PubMed ID: 16267513
    [No Abstract]   [Full Text] [Related]  

  • 3. Starting to gel.
    Pilcher H
    Nature; 2004 Jul; 430(6996):138-40. PubMed ID: 15241385
    [No Abstract]   [Full Text] [Related]  

  • 4. Africa, India test sites for anti-HIV microbicide. Cellulose sulfate tested in high-risk women.
    AIDS Alert; 2005 Mar; 20(3):34-6. PubMed ID: 15789474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. After microbicide failures, hope that antiviral approach will gel.
    Padma TV
    Nat Med; 2008 Apr; 14(4):354. PubMed ID: 18391925
    [No Abstract]   [Full Text] [Related]  

  • 6. Research. Topical anal microbicide reduces risk of HIV transmission in trial.
    AIDS Policy Law; 2011 Dec; 27(1):1, 4. PubMed ID: 22319817
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbicide data show promise.
    AIDS Patient Care STDS; 2009 Mar; 23(3):223-4. PubMed ID: 19480060
    [No Abstract]   [Full Text] [Related]  

  • 8. Public health. Regulatory challenges in microbicide development.
    Coplan PM; Mitchnick M; Rosenberg ZF
    Science; 2004 Jun; 304(5679):1911-2. PubMed ID: 15218130
    [No Abstract]   [Full Text] [Related]  

  • 9. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
    Fletcher PS; Shattock RJ
    Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot topics for FAQs.
    HIV Prev Plus; 2004; 5(4):2. PubMed ID: 16456956
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaginal microbicides: moving ahead after an unexpected setback.
    van de Wijgert JH; Shattock RJ
    AIDS; 2007 Nov; 21(18):2369-76. PubMed ID: 18025873
    [No Abstract]   [Full Text] [Related]  

  • 12. Scientists rethink approach to HIV gels.
    Check E
    Nature; 2007 Mar; 446(7131):12. PubMed ID: 17330015
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial and failure.
    Nature; 2007 Mar; 446(7131):1. PubMed ID: 17330004
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-HIV agents. Study finds PEP not 100% effective in preventing HIV infection.
    TreatmentUpdate; 2005; 17(6):7-9. PubMed ID: 17230631
    [No Abstract]   [Full Text] [Related]  

  • 15. Study: HIV prevention requires counseling.
    AIDS Policy Law; 2006 Apr; 21(7):1. PubMed ID: 16673476
    [No Abstract]   [Full Text] [Related]  

  • 16. Promising anti-HIV gel in large-scale study in women.
    Expert Rev Anti Infect Ther; 2009 May; 7(4):395. PubMed ID: 19400755
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbicides: anti-HIV efficacy and ethics.
    Wilson DP; Blower SM
    Science; 2004 Dec; 306(5703):1890; author reply 1890. PubMed ID: 15591184
    [No Abstract]   [Full Text] [Related]  

  • 18. Gel may hold promise for preventing HIV in women.
    AIDS Policy Law; 2009 Mar; 24(4):4. PubMed ID: 19526629
    [No Abstract]   [Full Text] [Related]  

  • 19. Miracle cure myth spurs unsafe sex.
    AIDS Patient Care STDS; 2001 Apr; 15(4):229. PubMed ID: 11359666
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase III anti-HIV microbicide trial in Africa and India stopped as preliminary results show gel may increase risk of infection.
    Editorial team
    Euro Surveill; 2007 Feb; 12(2):E070208.6. PubMed ID: 17370954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.